Bringing treatments to life
Accelerating value inflection with tailored clinical solutions
Clinical Redefined
80% of life-saving innovations come from emerging biotechs, yet getting them to patients is where the system breaks down. Reaching human PoC remains painfully slow, capital-intensive, and high-risk. Investors increasingly want more human patient data before committing further support. But the regulatory and competitive landscape now demands that companies move even faster, show more evidence, and stay more flexible.
More requirements. Fewer funds. Less time.
This is where Vivara Clinical comes in: to bridge the growing gap between concept and clinical proof with a faster, more budget sensible clinical strategy, so we can continue to see the best innovations help the most patients.
Tony Xu, PhD
Managing Director, Vivara
